Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability

ABSTRACT Forty-three percent (12/28) of ciprofloxacin (CIP)-nonsusceptible respiratory isolates of Haemophilus influenzae were hypermutable, compared with 8.5% (3/35) in the CIP-susceptible control group (P = 0.002). CIP-nonsusceptible mutants were obtained with hypermutable strains only; these mutants developed three resistance mechanisms in a step-by-step process: target modifications, loss of a porin protein, and increased efflux.

[1]  D. Hooper.  Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  R. Leclercq,et al.  Hypermutable and Fluoroquinolone-Resistant Clinical Isolates of Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[3]  Michael E. Watson,et al.  Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. , 2004, Microbiology.

[4]  J. Nazir,et al.  Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  T. Gootz,et al.  Genetic and Molecular Characterization of β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae with Unusually High Resistance to Ampicillin , 2004, Antimicrobial Agents and Chemotherapy.

[6]  J. Campos,et al.  Dynamics of Long-Term Colonization of Respiratory Tract by Haemophilus influenzae in Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable Strains , 2004, Journal of Clinical Microbiology.

[7]  J. Campos,et al.  Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC Mutations , 2004, Journal of Clinical Microbiology.

[8]  J. Campos,et al.  In Vitro Activities of Garenoxacin (BMS-284756) against Haemophilus influenzae Isolates with Different Fluoroquinolone Susceptibilities , 2003, Antimicrobial Agents and Chemotherapy.

[9]  J. Blázquez,et al.  Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Campos,et al.  Levofloxacin treatment failure in Haemophilus influenzae pneumonia. , 2003, Emerging infectious diseases.

[11]  J. Campos,et al.  Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance. , 2003, The Journal of antimicrobial chemotherapy.

[12]  L. Martínez-Martínez,et al.  Energy-Dependent Accumulation of Norfloxacin and Porin Expression in Clinical Isolates of Klebsiella pneumoniae and Relationship to Extended-Spectrum β-Lactamase Production , 2002, Antimicrobial Agents and Chemotherapy.

[13]  F. Taddei,et al.  Mutator Bacteria as a Risk Factor in Treatment of Infectious Diseases , 2002, Antimicrobial Agents and Chemotherapy.

[14]  Angela Lee,et al.  Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy , 2001, Antimicrobial Agents and Chemotherapy.

[15]  L. Martínez-Martínez,et al.  Energy-Dependent Accumulation of Fluoroquinolones in Quinolone-Resistant Klebsiella pneumoniae Strains , 1998, Antimicrobial Agents and Chemotherapy.

[16]  L. Martínez-Martínez,et al.  Energy-Dependent Accumulation of Fluoroquinolones in Quinolone-Resistant Klebsiella pneumoniaeStrains , 1998, Antimicrobial Agents and Chemotherapy.

[17]  A. Troelstra,et al.  Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The Netherlands. , 1997, The Journal of antimicrobial chemotherapy.

[18]  F. Baquero,et al.  Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. , 1996, The Journal of infectious diseases.

[19]  M. Georgiou,et al.  Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC , 1996, Antimicrobial agents and chemotherapy.

[20]  J. Hindler,et al.  Ciprofloxacin-Resistant Haemophilus Influenzae Infection in a Patient with Chronic Lung Disease , 1993, The Annals of pharmacotherapy.

[21]  S. Nakamura,et al.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli , 1990, Antimicrobial Agents and Chemotherapy.

[22]  D. Hooper,et al.  Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction , 1989, Antimicrobial Agents and Chemotherapy.

[23]  C. Slaughter,et al.  Primary structure of the porin protein of Haemophilus influenzae type b determined by nucleotide sequence analysis , 1989, Infection and immunity.